Registro:

Referencias:

• Chebib, M., Johnston, G.A., The 'ABC' of GABA receptors: a brief review (1999) Clin. Exp. Pharmacol. Physiol., 26, p. 937
• Rudolph, U., Mohler, H., GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism (2014) Annu. Rev. Pharmacol. Toxicol., 54, p. 483
• Johnston, G.A.R., GABAA receptor channel pharmacology (2005) Curr. Pharmaceut. Des., 11, p. 1867
• Hemmings, H.C., Jr., Akabas, M.H., Goldstein, P.A., Trudell, J.R., Orser, B.A., Harrison, N.L., Emerging molecular mechanisms of general anesthetic action (2005) Trends Pharmacol. Sci., 26, p. 503
• Sieghart, W., Allosteric modulation of GABAA receptors via multiple drug-binding sites (2015) Adv. Pharmacol., 72, p. 53
• Sigel, E., Steinmann, M.E., Structure, function, and modulation of GABA(A) receptors (2012) J. Biol. Chem., 287, p. 40224
• Dacosta, C.J., Baenziger, J.E., Gating of pentameric ligand-gated ion channels: structural insights and ambiguities (2013) Structure, 21, p. 1271
• Gasior, M., Carter, R.B., Witkin, J.M., Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders (1999) Trends Pharmacol. Sci., 20, p. 107
• Belelli, D., Lambert, J.J., Neurosteroids: endogenous regulators of the GABA(A) receptor (2005) Nat. Rev. Neurosci., 6, p. 565
• Reddy, D.S., Rogawski, M.A., Neurosteroids - Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy (2012) Jasper's Basic Mechanisms of the Epilepsies, , J.L. Noebels et al. (Eds.), Bethesda (MD)
• Akk, G., Covey, D.F., Evers, A.S., Steinbach, J.H., Zorumski, C.F., Mennerick, S., The influence of the membrane on neurosteroid actions at GABA(A) receptors (2009) Psychoneuroendocrinology, 34, p. S59
• Chisari, M., Eisenman, L.N., Covey, D.F., Mennerick, S., Zorumski, C.F., The sticky issue of neurosteroids and GABA(A) receptors (2010) Trends Neurosci., 33, p. 299
• Hosie, A.M., Wilkins, M.E., Da Silva, H.M., Smart, T.G., Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites (2006) Nature, 444, p. 486
• Hosie, A.M., Wilkins, M.E., Smart, T.G., Neurosteroid binding sites on GABA(A) receptors (2007) Pharmacol. Ther., 116, p. 7
• Li, G.D., Chiara, D.C., Cohen, J.B., Olsen, R.W., Neurosteroids allosterically modulate binding of the anesthetic etomidate to gamma-aminobutyric acid type A receptors (2009) J. Biol. Chem., 284, p. 11771
• Bali, M., Jansen, M., Akabas, M.H., GABA-induced intersubunit conformational movement in the GABAA receptor alpha 1M1-beta 2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site (2009) J. Neurosci., 29, p. 3083
• Williams, D.B., A mutant residue in the third transmembrane region of the GABA(A) alpha1 subunit causes increased agonistic neurosteroid responses (2011) Neurochem. Int., 58, p. 794
• Miller, P.S., Aricescu, A.R., Crystal structure of a human GABAA receptor (2014) Nature, 512, p. 270
• Davies, P.A., Kirkness, E.F., Hales, T.G., Modulation by general anaesthetics of rat GABAA receptors comprised of alpha 1 beta 3 and beta 3 subunits expressed in human embryonic kidney 293 cells (1997) Br. J. Pharmacol., 120, p. 899
• Chen, Z.W., Manion, B., Townsend, R.R., Reichert, D.E., Covey, D.F., Steinbach, J.H., Sieghart, W., Evers, A.S., Neurosteroid analog photolabeling of a site in the third transmembrane domain of the beta3 subunit of the GABA(A) receptor (2012) Mol. Pharmacol., 82, p. 408
• Wang, P., Mcinnes, C., Zhu, B.T., Structural characterization of the binding interactions of various endogenous estrogen metabolites with human estrogen receptor alpha and beta subtypes: a molecular modeling study (2013) PLoS One, 8
• Chakraborty, S., Levenson, A.S., Biswas, P.K., Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha (2013) BMC Struct. Biol., 13, p. 27
• Capelli, A.M., Bruno, A., Entrena Guadix, A., Costantino, G., Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor (2013) J. Med. Chem., 56, p. 7003
• Xu, X., Yang, W., Wang, X., Li, Y., Wang, Y., Ai, C., Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain (2011) Proteins, 79, p. 1154
• Alvarez, L.D., Dansey, M.V., Marti, M.A., Bertucci, P.Y., Di Chenna, P.H., Pecci, A., Burton, G., Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone (2011) Bioorg. Med. Chem., 19, p. 1683
• Alvarez, L.D., Marti, M.A., Veleiro, A.S., Presman, D.M., Estrin, D.A., Pecci, A., Burton, G., Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone (2008) J. Med. Chem., 51, p. 1352
• Alvarez, L.D., Marti, M.A., Veleiro, A.S., Misico, R.I., Estrin, D.A., Pecci, A., Burton, G., Hemisuccinate of 21-hydroxy-6,19-epoxyprogesterone: a tissue-specific modulator of the glucocorticoid receptor (2008) ChemMedChem., 3, p. 1869
• Bernardes, A., Souza, P.C., Muniz, J.R., Ricci, C.G., Ayers, S.D., Parekh, N.M., Godoy, A.S., Polikarpov, I., Molecular mechanism of peroxisome proliferator-activated receptor alpha activation by WY14643: a new mode of ligand recognition and receptor stabilization (2013) J. Mol. Biol., 425, p. 2878
• Le Guilloux, V., Schmidtke, P., Tuffery, P., Fpocket: an open source platform for ligand pocket detection (2009) BMC Bioinformat., 10, p. 168
• Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J., AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility (2009) J. Comput. Chem., 30, p. 2785
• Veleiro, A.S., Burton, G., Structure-activity relationships of neuroactive steroids acting on the GABAA receptor (2009) Curr. Med. Chem., 16, p. 455
• Li, P., Bandyopadhyaya, A.K., Covey, D.F., Steinbach, J.H., Akk, G., Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation (2009) Br. J. Pharmacol., 158, p. 1322
• Akk, G., Li, P., Bracamontes, J., Reichert, D.E., Covey, D.F., Steinbach, J.H., Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids (2008) Mol. Pharmacol., 74, p. 614
• Frisch, M.J., T, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Montgomery, J.A., Jr., Gonzalez, C., (2004) J.A. Pople Gaussian 03, , Revision C.02. Gaussian, Inc., Wallingford CT
• The PyMOL Molecular Graphics System, , Version 1.5.0.4 Schrödinger, LLC
• Case, D.A., B, V., Berryman, J.T., Betz, R.M., Cai, Q., Cerutti, D.S., Cheatham, T.E., III, Kollman, P.A., (2014) Amber 14, , University of California, San Francisco
• Wu, E.L., Cheng, X., Jo, S., Rui, H., Song, K.C., Davila-Contreras, E.M., Qi, Y., Im, W., CHARMM-GUI Membrane Builder toward realistic biological membrane simulations (2014) J. Comput. Chem., 35, p. 1997

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------